Most importantly Dr. Pierce is doing what he has done at MRK. Dr. Pierce is taking $ONCS EP + IL-12 program and showing all the complex chemistries that it is promoting. These chemistries are early markers for the progress for tumor responding and therefore pointing to success. The Pharma Reps understand this and most certainly there will be much discussions on Jun 2 when the $ONCS Abstract poster will be discussed.